Diabetes

2384's picture

Admission Blood Glucose Levels a Potential Indicator for Short Term Mortality and Morbidity After Myocardial Infarction

Journal Title, Volume, Page: 
nternational Journal of Diabetes in Developing Countries, 26 (3): 116-121
Year of Publication: 
2006
Authors: 
Abdel Naser Zaid
College of Pharmacy, Clinical Pharmacy Graduate Program, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Waleed M. Sweileh
Ansam F. Sawalha
Suha A. Salfeete
Sa'ed H. Zyoud
Adham S. Abu-Taha
Samah W. Al-Jabi
Nidal A. Jaradat
Preferred Abstract (Original): 

Aims:

Hyperglycemia is common among patients with acute myocardial infarction (AMI) and is associated with high risk of mortality and morbidity. However, the relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with AMI needs further investigation. The aim of this study was to investigate the relationship between APG level and short-term mortality and morbidity after AMI.

Materials And Methods:

This is a prospective study of 79 consecutive patients with AMI followed up for 90 days. Medical history, as well as demographic and clinical baseline characteristics, of the patients was obtained from Al-Watni Governmental Hospital medical records. The patients were divided into four groups based on APG levels. Patients' health status was followed up by phone call interviews with the patients and their families. Follow-up data were further confirmed using patients' medical records at the hospital. The phone interviews investigated all causes of death or congestive heart failure (CHF) or re-infarction.

Results:

The mean age of patients was 61.9 ± 12.3 years. At the time of hospital admission, the median PG level was 162 mg/dl. During the 3-month follow-up, overall mortality was 20.3% and was increased to 56.3% in patients with glucose levels >200 mg/dl. Mortality was comparable (21.9% vs. 19.1%; P > 0.05) between diabetic and nondiabetic patients. Nonfatal adverse outcomes in the form of combined CHF and re-infarction were highest in group IV and lowest in group I.

Conclusion:

Our study demonstrates that high APG level is common in patients with AMI and is associated with high risk of mortality and morbidity among patients with or without diabetes mellitus. In fact, our study showed that nondiabetic patients with high APG have higher risk of mortality than patients with a known history of diabetes mellitus.

MSShtayeh's picture

Complementary and Alternative Medicine Use amongst Palestinian Diabetic Patients

Journal Title, Volume, Page: 
Complementary Therapies in Clinical Practice Volume 18, Issue 1, February 2012, Pages 16–21
Year of Publication: 
2012
Authors: 
Mohammed S. Ali-Shtayeh
Department of Biology and Biotechnology, Faculty of Science, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Biology and Biotechnology, Faculty of Science, An-Najah National University, Nablus, Palestine
Rana M. Jamous
Department of Biology and Biotechnology, Faculty of Science, An-Najah National University, Nablus, Palestine
Rania M. Jamous
Department of Biology and Biotechnology, Faculty of Science, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

Objectives To measure the frequency of herbal medicine use among patients with diabetes mellitus in Palestine; to determine demographic characteristics that may increase the likelihood of Complementary and Alternative Medicine (CAM) use and to find out how benefits, if any, were perceived by patients.
Method Cross-sectional survey of patients attending the outpatient diabetes departments at 7 Governmental Hospitals. The method was based on semi-structured questionnaires.
Results A total of 1883 patients with diabetes were interviewed. Of the participants, 51.9% (n = 977) reported taking herbs primarily bought from Palestine (98%) and used in crude form mainly as decoctions (44.1%). The five most common herbal products used were: Trigonella berythea (Fabaceae) (n = 191, 19.6%), Rosmarinus officinalis (Lamiaceae) (n = 132, 13.5%), Olea europaea (Oleaceae) (n = 131, 13.4%), Teucrium capitatum (Lamiaceae) (n = 111, 11.4%), and Cinnamomum zeylanicum (Lauraceae) (n = 105, 10.8%). Most CAM users were above 40 years old 79.6% (n = 778), predominantly female (53.2%) and residents of refugee camps and rural areas (59.3, and 53.5, respectively). The recommendations of a family member or friend was the main factor prompting the use of CAM (40.2 and 37.1%). Most CAM users (71.7%) were satisfied with the perceived effects. Interestingly, 68% of patients recruited in the study did not disclose CAM use to their physicians or pharmacists.
Conclusion Use of herbal therapies in diabetes is highly prevalent in Palestine. More than 70% of those using CAM (977, 51.9%) reported positive benefits including a feeling of slowing down disease progression, symptom relief, disease resolution or a reduction in the side effects of allopathic medication. Use of CAM should be explored with patients before clinical decisions are made. There is a need for health education relating to herbal use in conjunction with conventional medicines in diabetes.  

Samahjabi's picture

Admission Blood Glucose Level As A Potential Indicator For Short-Term Mortality And Morbidity After Myocardial Infarction

Journal Title, Volume, Page: 
International Journal of Diabetes in Developing Countries, 2006, 26 (3): 116-121
Year of Publication: 
2006
Authors: 
Waleed M Sweileh
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Ansam F. Sawalha
Poison Control and Drug Information Center (PCDIC), An-Najah National University, Nablus, Occupied Palestinian Territory
Suha A Salfeete
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Sa'ed H. Zyoud
Poison Control and Drug Information Center (PCDIC), An-Najah National University
Adham S Abu-Taha
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Samah W. Al-Jabi
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Nidal Jaradat
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Abed Al-Naser M Zaid
Faculty of Pharmacy, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

Aims : Hyperglycemia is common among patients with acute myocardial infarction (AMI) and is associated with high risk of mortality and morbidity. However, the relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with AMI needs further investigation. The aim of this study was to investigate the relationship between APG level and short-term mortality and morbidity after AMI.
Materials And Methods : This is a prospective study of 79 consecutive patients with AMI followed up for 90 days. Medical history, as well as demographic and clinical baseline characteristics, of the patients was obtained from Al-Watni Governmental Hospital medical records. The patients were divided into four groups based on APG levels. Patients' health status was followed up by phone call interviews with the patients and their families. Follow-up data were further confirmed using patients' medical records at the hospital. The phone interviews investigated all causes of death or congestive heart failure (CHF) or re-infarction.
Results : The mean age of patients was 61.9 ± 12.3 years. At the time of hospital admission, the median PG level was 162 mg/dl. During the 3-month follow-up, overall mortality was 20.3% and was increased to 56.3% in patients with glucose levels >200 mg/dl. Mortality was comparable (21.9% vs. 19.1%; P > 0.05) between diabetic and nondiabetic patients. Nonfatal adverse outcomes in the form of combined CHF and re-infarction were highest in group IV and lowest in group I.
Conclusion :Our study demonstrates that high APG level is common in patients with AMI and is associated with high risk of mortality and morbidity among patients with or without diabetes mellitus. In fact, our study showed that nondiabetic patients with high APG have higher risk of mortality than patients with a known history of diabetes mellitus

saedzyoud's picture

Admission Blood Glucose Level As A Potential Indicator For Short-Term Mortality And Morbidity After Myocardial Infarction

Journal Title, Volume, Page: 
International Journal of Diabetes in Developing Countries, Year : 2006, Volume.26, Issue:3, Page:116-121
Year of Publication: 
2006
Authors: 
Waleed M Sweileh
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Ansam F Sawalha
Poison Control And Drug Information Center (PCDIC), An-Najah National University. Nablus, Palestine
Suha A Salfeete
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Sa'ed H Zyoud
Poison Control And Drug Information Center (PCDIC), An-Najah National University. Nablus, Palestine
Current Affiliation: 
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Adham S Abu-Taha
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Nidal A Jaradat
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Samah W Al-jabi
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Abed Al-Naser M Zaid
Department of Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

Aims :Hyperglycemia is common among patients with acute myocardial infarction (AMI) and is associated with high risk of mortality and morbidity. However, the relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with AMI needs further investigation. The aim of this study was to investigate the relationship between APG level and short-term mortality and morbidity after AMI.
Materials And Methods : This is a prospective study of 79 consecutive patients with AMI followed up for 90 days. Medical history, as well as demographic and clinical baseline characteristics, of the patients was obtained from Al-Watni Governmental Hospital medical records. The patients were divided into four groups based on APG levels. Patients' health status was followed up by phone call interviews with the patients and their families. Follow-up data were further confirmed using patients' medical records at the hospital. The phone interviews investigated all causes of death or congestive heart failure (CHF) or re-infarction.
Results :The mean age of patients was 61.9 ± 12.3 years. At the time of hospital admission, the median PG level was 162 mg/dl. During the 3-month follow-up, overall mortality was 20.3% and was increased to 56.3% in patients with glucose levels >200 mg/dl. Mortality was comparable (21.9% vs. 19.1%; P > 0.05) between diabetic and nondiabetic patients. Nonfatal adverse outcomes in the form of combined CHF and re-infarction were highest in group IV and lowest in group I.
Conclusion: Our study demonstrates that high APG level is common in patients with AMI and is associated with high risk of mortality and morbidity among patients with or without diabetes mellitus. In fact, our study showed that nondiabetic patients with high APG have higher risk of mortality than patients with a known history of diabetes mellitus

ansam's picture

Admission Blood Glucose Levels a Potential Indicator for Short Term Mortality and Morbidity after Myocardial Infarction

Journal Title, Volume, Page: 
Int J Diab Dev Ctries 26 3
Year of Publication: 
2006
Authors: 
Sawalha AF
Poison Control And Drug Information Center (PCDIC), An-Najah National University. Nablus, Palestine
Current Affiliation: 
Faculty of Medicine & Health Sciences, Department of Biomedical Sciences, An-Najah National University, Nablus, Palestine
Sweileh WM
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Salfeete S
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Zyoud SH
Poison Control And Drug Information Center (PCDIC), An-Najah National University. Nablus, Palestine
Abu-Taha AS
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Al-jabi SW
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Jaradat NA
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Zaid AA
College Of Pharmacy, An-Najah National University, Nablus, Palestine
Preferred Abstract (Original): 

Aims : Hyperglycemia is common among patients with acute myocardial infarction (AMI) and is associated with high risk of mortality and morbidity. However, the relationship between admission plasma glucose (APG) levels and mortality in diabetic and nondiabetic patients with AMI needs further investigation. The aim of this study was to investigate the relationship between APG level and short-term mortality and morbidity after AMI.
Materials And Methods :This is a prospective study of 79 consecutive patients with AMI followed up for 90 days. Medical history, as well as demographic and clinical baseline characteristics, of the patients was obtained from Al-Watni Governmental Hospital medical records. The patients were divided into four groups based on APG levels. Patients\' health status was followed up by phone call interviews with the patients and their families. Follow-up data were further confirmed using patients\' medical records at the hospital. The phone interviews investigated all causes of death or congestive heart failure (CHF) or re-infarction.
Results: The mean age of patients was 61.9 ± 12.3 years. At the time of hospital admission, the median PG level was 162 mg/dl. During the 3-month follow-up, overall mortality was 20.3% and was increased to 56.3% in patients with glucose levels >200 mg/dl. Mortality was comparable (21.9% vs. 19.1%; P > 0.05) between diabetic and nondiabetic patients. Nonfatal adverse outcomes in the form of combined CHF and re-infarction were highest in group IV and lowest in group I.
Conclusion : Our study demonstrates that high APG level is common in patients with AMI and is associated with high risk of mortality and morbidity among patients with or without diabetes mellitus. In fact, our study showed that nondiabetic patients with high APG have higher risk of mortality than patients with a known history of diabetes mellitus.

Syndicate content